196 related articles for article (PubMed ID: 25221363)
1. Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)-Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs-.
Kobayashi M; Fujinaga Y; Ota H
Acta Histochem Cytochem; 2014 May; 47(2):45-57. PubMed ID: 25221363
[TBL] [Abstract][Full Text] [Related]
2. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.
Castellano-Megías VM; Andrés CI; López-Alonso G; Colina-Ruizdelgado F
World J Gastrointest Oncol; 2014 Sep; 6(9):311-24. PubMed ID: 25232456
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract][Full Text] [Related]
4. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
5. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis.
Basturk O; Khayyata S; Klimstra DS; Hruban RH; Zamboni G; Coban I; Adsay NV
Am J Surg Pathol; 2010 Mar; 34(3):364-70. PubMed ID: 20139757
[TBL] [Abstract][Full Text] [Related]
7. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
8. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
Adsay NV; Merati K; Basturk O; Iacobuzio-Donahue C; Levi E; Cheng JD; Sarkar FH; Hruban RH; Klimstra DS
Am J Surg Pathol; 2004 Jul; 28(7):839-48. PubMed ID: 15223952
[TBL] [Abstract][Full Text] [Related]
9. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
10. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
[TBL] [Abstract][Full Text] [Related]
11. Intraductal Papillary Mucinous Neoplasms Often Contain Epithelium From Multiple Subtypes and/or Are Unclassifiable.
Schaberg KB; DiMaio MA; Longacre TA
Am J Surg Pathol; 2016 Jan; 40(1):44-50. PubMed ID: 26469398
[TBL] [Abstract][Full Text] [Related]
12. Intraductal tubular adenomas (pyloric gland-type) of the pancreas: clinicopathologic features are similar to gastric-type intraductal papillary mucinous neoplasms and different from intraductal tubulopapillary neoplasms.
Chang X; Jiang Y; Li J; Chen J
Diagn Pathol; 2014 Sep; 9():172. PubMed ID: 25245835
[TBL] [Abstract][Full Text] [Related]
13. How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.
Omori Y; Ono Y; Kobayashi T; Motoi F; Karasaki H; Mizukami Y; Makino N; Ueno Y; Unno M; Furukawa T
Virchows Arch; 2020 Jul; 477(1):21-31. PubMed ID: 32291497
[TBL] [Abstract][Full Text] [Related]
14. Fundic gland differentiation of oncocytic/pancreatobiliary subtypes of pancreatic intraductal papillary mucinous neoplasm.
Mamat O; Fukumura Y; Saito T; Takahashi M; Mitomi H; Sai JK; Kawasaki S; Yao T
Histopathology; 2016 Oct; 69(4):570-81. PubMed ID: 26990132
[TBL] [Abstract][Full Text] [Related]
15. Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Distler M; Kersting S; Niedergethmann M; Aust DE; Franz M; Rückert F; Ehehalt F; Pilarsky C; Post S; Saeger HD; Grützmann R
Ann Surg; 2013 Aug; 258(2):324-30. PubMed ID: 23532107
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
[TBL] [Abstract][Full Text] [Related]
17. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
19. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
[TBL] [Abstract][Full Text] [Related]
20. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]